Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles B Scott

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
American Journal of Clinical Oncology|December 15, 2004
Does stereotactic eligibility for the treatment of glioblastoma cause selection bias in randomized studies?Robert A Lustig, Charles B Scott, Walter J Curran
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology GroupDavid W Johnstone, Roger W Byhardt, David Ettinger, et al.
Clinical Immunology (Orlando, Fla.)|September 30, 2024
Broad applicability of the Goldspire™ platform for the treatment of solid tumorsJenny Zilberberg, Christopher Uhl, Charles B Scott, et al.
Journal of Child Neurology|January 22, 2013
Vitamin D intake is inadequate in spinal muscular atrophy type I cohort: correlations with bone healthJennifer Aton, Rebecca Hurst Davis, Kristine C Jordan, et al.
International Journal of Radiation Oncology, Biology, Physics|March 2, 2002
Impact of institutional experience on survival outcome of patients undergoing combined chemoradiation therapy for inoperable non-small-cell lung cancerJin S Lee, Charles B Scott, Ritsuko Komaki, et al.
Cancer Investigation|December 8, 2004
Prediction of survival for advanced cancer patients by recursive partitioning analysis: role of Karnofsky performance status, quality of life, and symptom distressShirley S Hwang, Charles B Scott, Victor T Chang, et al.
Journal of Pain and Symptom Management|April 28, 2015
Patient-Reported Outcomes for Determining Prognostic Groups in Veterans With Advanced CancerVictor T Chang, Charles B Scott, Melanie L Gonzalez, et al.
Muscle & Nerve|June 24, 2011
Reliability of the Modified Hammersmith Functional Motor Scale in young children with spinal muscular atrophyKristin J Krosschell, Charles B Scott, Jo Anne Maczulski, et al.
American Journal of Clinical Oncology|September 1, 2007
Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03William F Hartsell, Charles B Scott, George S Dundas, et al.
Annals of Neurology|April 27, 2005
Natural history of denervation in SMA: relation to age, SMN2 copy number, and functionKathryn J Swoboda, Thomas W Prior, Charles B Scott, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
American Journal of Clinical Oncology|December 15, 2004
Does stereotactic eligibility for the treatment of glioblastoma cause selection bias in randomized studies?Robert A Lustig, Charles B Scott, Walter J Curran
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology GroupDavid W Johnstone, Roger W Byhardt, David Ettinger, et al.
Clinical Immunology (Orlando, Fla.)|September 30, 2024
Broad applicability of the Goldspire™ platform for the treatment of solid tumorsJenny Zilberberg, Christopher Uhl, Charles B Scott, et al.
Journal of Child Neurology|January 22, 2013
Vitamin D intake is inadequate in spinal muscular atrophy type I cohort: correlations with bone healthJennifer Aton, Rebecca Hurst Davis, Kristine C Jordan, et al.
International Journal of Radiation Oncology, Biology, Physics|March 2, 2002
Impact of institutional experience on survival outcome of patients undergoing combined chemoradiation therapy for inoperable non-small-cell lung cancerJin S Lee, Charles B Scott, Ritsuko Komaki, et al.
Cancer Investigation|December 8, 2004
Prediction of survival for advanced cancer patients by recursive partitioning analysis: role of Karnofsky performance status, quality of life, and symptom distressShirley S Hwang, Charles B Scott, Victor T Chang, et al.
Journal of Pain and Symptom Management|April 28, 2015
Patient-Reported Outcomes for Determining Prognostic Groups in Veterans With Advanced CancerVictor T Chang, Charles B Scott, Melanie L Gonzalez, et al.
Muscle & Nerve|June 24, 2011
Reliability of the Modified Hammersmith Functional Motor Scale in young children with spinal muscular atrophyKristin J Krosschell, Charles B Scott, Jo Anne Maczulski, et al.
American Journal of Clinical Oncology|September 1, 2007
Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03William F Hartsell, Charles B Scott, George S Dundas, et al.
Annals of Neurology|April 27, 2005
Natural history of denervation in SMA: relation to age, SMN2 copy number, and functionKathryn J Swoboda, Thomas W Prior, Charles B Scott, et al.
Pageof 3